![Yuan Xu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yuan Xu
Director/Board Member at
FATE THERAPEUTICS, INC.
Net worth: 21 239 $ as of 2026-07-30
Profile
Yuan J.
Xu is currently an Independent Director at Fate Therapeutics, Inc. since 2021 and an Independent Director at Xilio Therapeutics, Inc. since 2022.
Former roles include Chief Executive Officer & Director at Legend Biotech Corp.
from 2018 to 2020, Independent Director at Akero Therapeutics, Inc. from 2021 to 2025, Vice President-Biologics at Gilead Sciences, Inc. from 2014 to 2015, Senior Vice President at Merck & Co., Inc. from 2015 to 2017, and Vice President at Novartis AG from 2008 to 2014.
Education includes a doctorate from the University of Maryland and an undergraduate degree from Nanjing University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-11 | 8,669 ( 0.01% ) | 21 239 $ | 2026-07-30 | |
LEGEND BIOTECH CORP. -.--% | 2020-06-07 | 0 ( -.--% ) | - $ | 2026-07-30 |
| 2026-06-10 | 0 ( -.--% ) | - $ | 2026-07-30 |
Latest news about Yuan Xu
Yuan Xu active positions
| Companies | Position | Start |
|---|---|---|
| FATE THERAPEUTICS, INC. | Director/Board Member | 2021-08-02 |
| XILIO THERAPEUTICS, INC. | Director/Board Member | 2022-01-03 |
Former positions of Yuan Xu
| Companies | Position | End |
|---|---|---|
| AKERO THERAPEUTICS, INC. | Director/Board Member | 2025-12-08 |
| LEGEND BIOTECH CORPORATION | Chief Executive Officer | 2020-07-31 |
| MERCK & CO., INC. | Corporate Officer/Principal | 2017-07-31 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 2015-07-31 |
| NOVARTIS AG | Corporate Officer/Principal | 2013-12-31 |
Training of Yuan Xu
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
72
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
University of Maryland
 University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nanjing University
 Nanjing University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fate Therapeutics, Inc.
 Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Legend Biotech Corp.
 Legend Biotech Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which engages in the discovery and development of novel cell therapies for oncology | Health Technology |
Xilio Therapeutics, Inc.
 Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies | Health Technology |
Akero Therapeutics, Inc.
 Akero Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for patients with metabolic diseases | Health Technology |
- Stock Market
- Insiders
- Yuan Xu
